CD Human Papillomavirus (HPV31) gDNA Quality Control Product

CAT Size Inquiry Basket
HNATQC004 100 μL/stem


Product Infomation
Product Description: Cervical cancer is the only gynecologic malignancy of clear etiology associated with persistent infection with high-risk human papillomavirus (HPV). HPV testing is an internationally recognized test that can be developed into primary screening for cervical cancer. Organizations conducting HPV testing need to select kits with stable performance to carry out the corresponding tests. The use of quality control products is particularly important for the accuracy verification of different kits.

CD has prepared nucleic acid assay controls by integrating HPV whole genome sequences in human cell lines, and the products contain controls for all HPV typing, including high-risk and low-risk types.
Features: Buffer: Tris-EDTA (10mM Tris-HCl, 1mM EDTA), pH 8.0
•HPV genome-wide integrated cell line background with good interoperability with clinical samples.
•HPV whole genome sequence with good adaptability to the assay product.
•Comprehensive HPV typing categories, covering all HPV typing associated with cervical cancer as proposed by the HPV Technical Review Guidelines and WHO, and the typing categories continue to expand.
•HPV genomic copy number is accurately quantified by digital PCR, and the product performance is stable.
•HPV genomic copy number quantification can be traced back to the WHO first generation HPV DNA international reference product.
Method: Quality Control Method: ddPCR
Concentration: 4*107 copies/mL
Sample Type: gDNA Solution
Application: • For performance validation and production quality control of HPV genotyping and nucleic acid assay kits.
• It is applicable to the indoor quality control of HPV genotyping and nucleic acid assay, monitoring the precision and accuracy of the assay process.
Storage: Store at 2-8℃, 36 months.
* For Research Use Only. Not for use in diagnostic procedures.
Copyright © 2024 CD Genomics. All rights reserved.
Inquiry Basket